0 avis
Continuous lipase-catalyzed production of pseudo-ceramides in a packed-bed bioreactor
Archive ouverte
Edité par CCSD ; Elsevier [1995, vol. 1, iss. 1-2016, vol. 134] -
International audience. Ceramides are spingolipid compounds that are very attractive as active components in both the phar-maceutical and the cosmetic industries. In this study, the synthesis of ceramide analogs, the so-calledpseudo-ceramides, was carried out using for the first time a two-step continuous enzymatic processwith immobilized Candida antarctica lipase B (Novozym®435) in a packed-bed bioreactor. The first stepinvolved the selective N-acylation of 3-amino-1,2-propanediol using stearic acid as the first acyl donor(i). This was followed by the selective O-acylation of the N-stearyl 3-amino-1,2-propanediol synthesizedin the first step, with myristic acid as the second acyl donor, to produce a N,O-diacyl 3-amino-1,2-propanediol-type pseudo-ceramide, namely 1-O-myristyl,3-N-stearyl 3-amino-1,2-propanediol (ii). Theprocess was first optimized by evaluating the influences of three factors: feed flow rate, quantity of bio-catalyst and substrate concentration. Under optimal conditions an amide synthesis yield of 92% and asatisfying production rate of almost 3.15 mmol h−1gbiocatalyst−1(1128 mg h−1gbiocatalyst−1) were obtained.The second step, N-acyl 3-amino-1,2-propanediol O-acylation, was similarly optimized and in additionthe effect of the substrate molar ratio was studied. Thus, an optimal pseudo-ceramide synthesis yield of54% and a production rate of 0.46 mmol h−1gbiocatalyst−1(261 mg h−1gbiocatalyst−1) were reached at a 1:3ratio of amide to fatty acid. In addition, it was demonstrated that this two-step process has great potentialfor the production of N,O-diacyl 3-amino-1,2-propanediol-type pseudo-ceramides on an industrial scale.It was shown in particular that Novozym®435 could be used for more than 3 weeks without a drop inthe yield during the first step of 3-amino-1,2-propanediol N-acylation, proving that this biocatalyst isvery stable under these operational conditions. This factor would greatly reduce the need for biocatalystreplacement and significantly lower the associated cost.
Consulter en ligne
Suggestions
Du même auteur
